Literature DB >> 25064176

A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X.

James Dollard1, Peter Kearney2, Gerard Clarke3, Gerard Moloney4, John F Cryan4, Timothy G Dinan5.   

Abstract

Cardiac Syndrome X (CSX), the presence of angina pectoris despite normal epicardial coronary arteries seen on invasive angiography, is known to be associated with an elevation of several inflammatory biomarkers, suggesting a possible role for inflammation in its pathogenesis. We sought to establish if C-reactive protein (CRP) levels varied with disease severity and so whether it is a state or trait marker. We studied 16 CSX patients with typical angina pectoris, normal coronary arteries and an electrically positive exercise stress test (EST) and 13 age- and sex-matched healthy controls (HC). CSX patients were followed up at a subsequent visit with repeated exercise stress testing and CRP measurement. We found that CRP levels were significantly higher in the CSX group compared to the HC (1.5 [0.8-4.5] v 0.8 [0.4-1.4] mg/L, p=0.02). This elevation in CRP persisted throughout the study length. CRP correlated with time to symptoms on EST at enrolment and at the second visit (r=-0.690, df=10, p=0.013 and r=-0.899, df=4, p=0.015, respectively). At the follow-up visit, 50% of CSX patients developed electrically and symptomatically negative ESTs. The mean CRP of this group was significantly lower than that of the CSX patients with ongoing symptoms and positive ESTs (1.2±0.2 v 2.8±0.6mg/L, p=0.018) and did not differ significantly from that of healthy controls. CRP levels also dropped in patients whose symptoms improved while they increased in patients who became more symptomatic (p=0.027). We conclude that the results of this small study support the concept of CSX being an inflammatory-mediated condition with CRP levels prospectively varying with functional measures of disease severity. This indicates that CRP is a state marker in CSX.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angina pectoris; C-reactive protein; Inflammation; Microvascular angina; Normal coronary arteries; Stress

Mesh:

Substances:

Year:  2014        PMID: 25064176     DOI: 10.1016/j.bbi.2014.07.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  3 in total

1.  Receptor for advanced glycation end products gene polymorphisms in cardiac syndrome X.

Authors:  Burak Önal; Deniz Özen; Bülent Demir; Ahmet G Akkan; Sibel Özyazgan
Journal:  Biomed Rep       Date:  2019-07-22

2.  Cardiac syndrome X in Ireland: incidence and phenotype.

Authors:  J Dollard; P Kearney; T G Dinan
Journal:  Ir J Med Sci       Date:  2015-11-27       Impact factor: 1.568

Review 3.  Inflammation in Coronary Microvascular Dysfunction.

Authors:  Marios Sagris; Panagiotis Theofilis; Alexios S Antonopoulos; Evangelos Oikonomou; Christina Paschaliori; Nikolaos Galiatsatos; Kostas Tsioufis; Dimitris Tousoulis
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.